NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699

Por Hunter, Jill E., Willmore, Elaine, Irving, Julie A. E., Hostomsky, Zdenek, Veuger, Stephany J., Durkacz, Barbara W.
Publicado em 2011

CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response

Por Dixon, Zach A., Nicholson, Lindsay, Zeppetzauer, Martin, Matheson, Elizabeth, Sinclair, Paul, Harrison, Christine J., Irving, Julie A.E.
Publicado no Haematologica (2017)

MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells

Por Brito, Jose L.R., Walker, Brian, Jenner, Matthew, Dickens, Nicholas J., Brown, Nicola J.M., Ross, Fiona M., Avramidou, Athanasia, Irving, Julie A.E., Gonzalez, David, Davies, Faith E., Morgan, Gareth J.
Publicado em 2009

Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia

Por Papaemmanuil, Elli, Hosking, Fay J, Vijayakrishnan, Jayaram, Price, Amy, Olver, Bianca, Sheridan, Eammon, Kinsey, Sally E, Lightfoot, Tracy, Roman, Eve, Irving, Julie A E, Allan, James M., Tomlinson, Ian P, Taylor, Malcolm, Greaves, Mel, Houlston, Richard S
Publicado no Nat Genet (2009)

Quantitative proteomic analysis reveals maturation as a mechanism underlying glucocorticoid resistance in B lineage ALL and re‐sensitization by JNK inhibition

Por Nicholson, Lindsay, Evans, Caroline A., Matheson, Elizabeth, Minto, Lynne, Keilty, Christopher, Sanichar, Maryna, Case, Marian, Schwab, Claire, Williamson, Daniel, Rainer, Johannes, Harrison, Christine J., Kofler, Reinhard, Hall, Andrew G., Redfern, Christopher P. F., Whetton, Anthony D., Irving, Julie A. E.
Publicado no Br J Haematol (2015)

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

Por Irving, Julie A. E., Enshaei, Amir, Parker, Catriona A., Sutton, Rosemary, Kuiper, Roland P., Erhorn, Amy, Minto, Lynne, Venn, Nicola C., Law, Tamara, Yu, Jiangyan, Schwab, Claire, Davies, Rosanna, Matheson, Elizabeth, Davies, Alysia, Sonneveld, Edwin, den Boer, Monique L., Love, Sharon B., Harrison, Christine J., Hoogerbrugge, Peter M., Revesz, Tamas, Saha, Vaskar, Moorman, Anthony V.
Publicado no Blood (2016)

Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk

Por Sherborne, Amy L, Hosking, Fay J, Prasad, Rashmi B, Kumar, Rajiv, Koehler, Rolf, Vijayakrishnan, Jayaram, Papaemmanuil, Elli, Bartram, Claus R, Stanulla, Martin, Schrappe, Martin, Gast, Andreas, Dobbins, Sara E, Ma, Yussanne, Sheridan, Eamonn, Taylor, Malcolm, Kinsey, Sally E, Lightfoot, Tracey, Roman, Eve, Irving, Julie A E, Allan, James M, Moorman, Anthony V, Harrison, Christine J, Tomlinson, Ian P, Richards, Sue, Zimmermann, Martin, Szalai, Csaba, Semsei, Ágnes F, Erdelyi, Daniel J, Krajinovic, Maja, Sinnett, Daniel, Healy, Jasmine, Neira, Anna Gonzalez, Kawamata, Norihiko, Ogawa, Seishi, Koeffler, H Phillip, Hemminki, Kari, Greaves, Mel, Houlston, Richard S
Publicado em 2010